Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8793344 | Journal Français d'Ophtalmologie | 2018 | 9 Pages |
Abstract
Infectious keratitis are a frequent cause of ocular morbidity. Today, new treatments are necessary to combat the emergence of antibiotic resistant germs. Corneal collagen cross-linking has been suggested to treat corneal infectious (PACK-CXL). Its action would be both antimicrobial and protective for the cornea, increasing its biochemical resistence to proteolytic enzymes. In vivo, PACK-CXL might demonstrate good efficacy against bacterial keratitis, contrary to herpetic keratitis for which it is contraindicated. For fungal or amoebic keratitis, results are uncertain regarding its safety and efficacy. The purpose of this paper is to clarify the use of corneal collagen cross-linking to treat infectious keratitis.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
R. Atia, L. Jouve, J. Knoeri, C. Georgeon, L. Laroche, V. Borderie, N. Bouheraoua,